Detail akcie Int Brand Licens online

Business Summary: EKF Diagnostics Holdings plc is a diagnostics and biotechnology company specializing in the manufacturing and distribution of advanced medical technologies and patient-focused solutions. The Company develops and produces in-vitro diagnostic (IVD) devices and tests designed for use at or near the patient’s location. It provides a suite of products for diabetes management, including glucose monitoring systems and associated consumables. It offers devices, supplies, and consumables for measuring hemoglobin levels, including tools for detecting hemoglobin variants. It also develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and biomaterials. It provides precision fermentation, custom bioprocessing, and contract manufacturing services for pharmaceuticals and other biological products. It supplies beta-hydroxybutyrate (HB) products used in ketone detection to support the diagnosis of diabetic ketoacidosis and other clinical conditions.
Financial Summary: BRIEF: For the six months ended 30 June 2025, EKF Diagnostics Holdings PLC revenues remained flat at L25.2M. Net income decreased 6% to L1.9M. Revenues reflect Germany segment increase of 5% to L10.4M, Russia segment increase of 21% to L2M, Rest of America segment increase of 33% to L1.9M, Russia segment increase of 21% to L2M, Germany segment increase of 4% to L3.8M, also reflect USA segment decrease of 6% to L12.9M.